Jamieson Wellness Inc (JWEL) AI Stock Analysis

• Market Cap: C$1.45B
• Dividend Yield: 2.45%
• Average Volume (3M): 59.01K
• Price to Earnings (P/E): 24.9
• Beta (1Y): 1.05
• Revenue Growth: 11.25%
• EPS Growth: 58.21%
• Country: CA
• Employees: 891
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.41
• Shares Outstanding: 41,932,747
• 10 Day Avg. Volume: 47,826
• 30 Day Avg. Volume: 59,011
• PEG Ratio: 3.05
• Price to Book (P/B): 3.02
• Price to Sales (P/S): 2.08
• P/FCF Ratio: 29.69
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: C$42.67
• Price Target Upside: 21.60% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 76 Outperform
• Price Target: C$40.00 ▲(13.99% Upside)

Jamieson Wellness Inc's strong financial performance and positive earnings call guidance are the primary drivers of its stock score. While technical indicators are neutral and valuation is moderate, the company's growth prospects, particularly in international markets, support a favorable outlook.

Positive Factors

Revenue Growth

Strong revenue growth indicates robust market demand and effective sales strategies, particularly in international markets, enhancing long-term business sustainability.

International Market Expansion

Successful expansion in China and other international markets diversifies revenue streams and reduces dependency on domestic sales, supporting long-term growth.

Profit Margin Improvements

Improved profit margins reflect efficient operations and a favorable sales mix, enhancing profitability and providing a buffer against cost pressures.

Negative Factors

Rising SG&A Expenses

Rising SG&A expenses can pressure margins and indicate potential inefficiencies, which may affect profitability if not managed effectively.

Strategic Partners Segment Decline

Decline in the Strategic Partners segment could signal challenges in maintaining partnerships, impacting revenue diversification and growth potential.

EBIT Margin Pressure

Pressure on EBIT margins suggests potential cost management issues, which could affect long-term profitability if not addressed.

Jamieson Wellness Inc Business Overview & Revenue Model

Company Description

Jamieson Wellness Inc. (JWEL) is a leading Canadian manufacturer and distributor of health and wellness products, specializing in dietary supplements, vitamins, and herbal remedies. Founded in 1922, the company operates within the health and wellness sector, focusing on high-quality, natural products designed to support overall health and well-being. Jamieson Wellness offers a diverse range of products, including vitamins, minerals, and herbal supplements, catering to a wide array of consumer health needs.

How the Company Makes Money

Jamieson Wellness generates revenue primarily through the sale of its health and wellness products across various channels, including retail, online, and direct-to-consumer sales. The company's key revenue streams include sales of vitamins, dietary supplements, and personal care products. Additionally, JWEL benefits from partnerships with major retailers and e-commerce platforms, enhancing its market reach. The company also engages in private label manufacturing, producing products for other brands, which serves as a significant source of income. Furthermore, Jamieson Wellness leverages its strong brand reputation and consumer trust to maintain competitive pricing and encourage repeat purchases, thereby contributing to its overall earnings.

Jamieson Wellness Inc Financial Statement Overview

Summary

Jamieson Wellness Inc exhibits strong financial health with consistent revenue growth and profitability. The company maintains a balanced leverage position and effective cash flow management. Minor areas for improvement include EBIT margin stabilization and cash flow coverage.

Income Statement

Jamieson Wellness Inc has demonstrated consistent revenue growth, with a TTM (Trailing-Twelve-Months) revenue increase of 1.9%. The company maintains healthy gross and net profit margins, with the TTM gross profit margin at 38.3% and net profit margin at 7.1%. EBIT and EBITDA margins are stable, indicating efficient operations. However, the slight decline in EBIT margin from the previous year suggests potential cost pressures.

Balance Sheet

The company's balance sheet shows a moderate debt-to-equity ratio of 0.61, indicating a balanced approach to leveraging. Return on Equity (ROE) is solid at 11.4%, reflecting effective use of equity to generate profits. However, the equity ratio is not explicitly provided, which limits a full assessment of asset financing stability.

Cash Flow

Jamieson Wellness Inc has shown strong free cash flow growth of 4.15% in the TTM period. The operating cash flow to net income ratio of 0.78 and free cash flow to net income ratio of 0.89 indicate good cash conversion efficiency. The company has improved its cash flow metrics over time, though the operating cash flow coverage ratio suggests room for improvement in cash flow management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	766.01M	733.78M	676.17M	547.37M	451.03M	403.66M
Gross Profit	303.83M	275.61M	233.56M	198.34M	162.44M	144.76M
EBITDA	121.92M	114.60M	108.78M	100.17M	90.40M	75.30M
Net Income	58.00M	51.91M	47.88M	52.81M	52.08M	41.60M
Balance Sheet
Total Assets	1.17B	1.21B	1.14B	1.11B	652.48M	609.34M
Cash, Cash Equivalents and Short-Term Investments	50.54M	44.79M	36.86M	26.24M	6.78M	1.17M
Total Debt	417.65M	308.29M	462.99M	400.00M	149.13M	149.06M
Total Liabilities	658.93M	660.41M	662.38M	675.67M	310.45M	316.94M
Stockholders Equity	468.37M	505.18M	438.93M	431.59M	342.02M	292.40M
Cash Flow
Free Cash Flow	93.42M	51.41M	22.41M	36.02M	22.12M	27.43M
Operating Cash Flow	104.97M	61.58M	31.71M	50.59M	44.41M	40.60M
Investing Cash Flow	-20.24M	-10.16M	-35.13M	-256.53M	-22.28M	-13.17M
Financing Cash Flow	-56.68M	-45.43M	14.04M	225.41M	-16.51M	-26.46M

Jamieson Wellness Inc Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 35.09
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:JWEL, the sentiment is Positive. The current price of 35.09 is above the 20-day moving average (MA) of 34.61, below the 50-day MA of 35.75, and above the 200-day MA of 33.64, indicating a neutral trend. The MACD of -0.23 indicates Negative momentum. The RSI at 50.35 is Neutral, neither overbought nor oversold. The STOCH value of 61.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:JWEL.

Jamieson Wellness Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JWEL	76 Outperform	C$1.45B	24.92	13.44%	2.45%	11.25%	58.21%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
BABY	42 Neutral	C$4.12M	―	-2576.83%	―	-22.92%	39.22%
NPRA	37 Underperform	C$11.99M	―	―	―	64.79%	72.95%
CULT	33 Underperform	C$1.41M	-0.20	-222.61%	―	―	-86.17%
PNGA	27 Underperform	C$6.06M	-2.93	-89.04%	―	-49.04%	14.85%

Jamieson Wellness Inc Corporate Events

Jamieson Wellness Inc. Achieves Strong Q3 2025 Growth Amid Global Expansion

Jamieson Wellness Inc. reported a robust third quarter for 2025, with a 13.2% increase in consolidated revenue driven by a 16.5% growth in its branded products. The company saw significant gains across various regions, with standout performances in China and the Middle East, bolstered by innovative marketing strategies and product developments. Despite a volatile macroeconomic environment, Jamieson’s diverse product offerings and strategic marketing have reinforced its market position, leading to increased consumer engagement and shareholder value.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$38.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Jamieson Wellness to Announce Q3 2025 Financial Results

Jamieson Wellness Inc. announced it will release its third quarter 2025 financial results on November 6, 2025, followed by a conference call for investors. This announcement is part of the company’s ongoing efforts to maintain transparency and engage with stakeholders, potentially impacting its market positioning and investor relations.

The most recent analyst rating on (TSE:JWEL) stock is a Hold with a C$37.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Jamieson Wellness Appoints Digital Expert Gayle Tait to Board of Directors

Jamieson Wellness Inc. has appointed Gayle Tait to its Board of Directors, bringing her extensive expertise in digital innovation and global consumer packaged goods to the company. This strategic move aims to enhance Jamieson’s growth in the digital and social e-commerce space within the vitamins, minerals, and supplements (VMS) market. Tait’s background includes leadership roles at Google Play and L’Oréal UK, and her experience is expected to support Jamieson’s expansion and adaptation to the evolving digital landscape, aligning with the company’s mission to inspire better lives through high-quality health products.

The most recent analyst rating on (TSE:JWEL) stock is a Hold with a C$37.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.